In the present study, we also observed that altered Notch1 activity in TNBC–related MDA-MB-231 cells results in the increased sensitivity of these cells for CDDP treatment, proving that measuring the prognostic value of Notch1 expression can help to guide individual therapy for BC patients, as suggested in other reports [35]. The gene discussed is NOTCH1; the disease is breast cancer.